tradingkey.logo

Fortrea Holdings Inc

FTRE
14.650USD
+0.850+6.16%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
1.35BCap. mercado
PérdidaP/E TTM

Fortrea Holdings Inc

14.650
+0.850+6.16%

Más Datos de Fortrea Holdings Inc Compañía

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Información de Fortrea Holdings Inc

Símbolo de cotizaciónFTRE
Nombre de la empresaFortrea Holdings Inc
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoThakrala (Anshul)
Número de empleados15500
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 16
Dirección8 Moore Drive
CiudadDURHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Teléfono18774950816
Sitio Webhttps://www.fortrea.com/
Símbolo de cotizaciónFTRE
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoThakrala (Anshul)

Ejecutivos de Fortrea Holdings Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+62500.00%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+7282.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+7282.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+5097.00%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
+7282.00%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+62500.00%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+7282.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+7282.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+5097.00%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
+7282.00%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
North America
332.70M
47.44%
Europe
213.20M
30.40%
Other
155.40M
22.16%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: sáb., 7 de feb
Actualizado: sáb., 7 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.99%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
Otro
59.47%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.99%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
Otro
59.47%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
46.19%
Hedge Fund
23.05%
Investment Advisor/Hedge Fund
18.36%
Research Firm
13.93%
Pension Fund
1.43%
Bank and Trust
1.36%
Individual Investor
0.50%
Family Office
0.33%
Holding Company
0.05%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
2023Q3
611
90.56M
44.21%
+51.30M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
12.67M
13.71%
-72.73K
-0.57%
Sep 30, 2025
The Vanguard Group, Inc.
8.03M
8.69%
-481.87K
-5.66%
Sep 30, 2025
Goldman Sachs & Company, Inc.
7.89M
8.54%
+148.09K
+1.91%
Sep 30, 2025
Corvex Management LP
4.51M
4.88%
--
--
Sep 30, 2025
State Street Investment Management (US)
4.07M
4.41%
-361.04K
-8.15%
Sep 30, 2025
Sessa Capital
3.99M
4.32%
--
--
Sep 30, 2025
AQR Capital Management, LLC
3.74M
4.04%
-2.78M
-42.66%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.97M
3.21%
-11.70K
-0.39%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
2.65M
2.87%
+863.47K
+48.25%
Sep 30, 2025
DWS Investments UK Limited
2.55M
2.76%
+921.34K
+56.67%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
Ver más
Brandes US Small-Mid Cap Value ETF
Proporción1.39%
Invesco S&P Spin-Off ETF
Proporción0.97%
Invesco S&P SmallCap Health Care ETF
Proporción0.58%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.25%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.23%
Schwab Fundamental U.S. Small Company ETF
Proporción0.17%
iShares S&P Small-Cap 600 Value ETF
Proporción0.16%
Humankind US Stock ETF
Proporción0.14%
ProShares Ultra Nasdaq Biotechnology
Proporción0.14%
State Street SPDR S&P 600 Small Cap Value ETF
Proporción0.13%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI